Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers Results available

A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 Years

ClinicalTrials.gov ID: NCT00952419

Public ClinicalTrials.gov record NCT00952419. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 9:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Immunogenicity and Safety of Multiple Formulations of an A/H1N1 Pandemic Vaccine in Healthy Subjects Aged 6 Months to 9 Years

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to evaluate different doses of the Influenza A/H1N1 pandemic vaccine in toddlers and children. Primary Objectives: * To describe the immunogenicity of the candidate vaccines after each injection. * To describe the safety of the candidate vaccines after each injection.

Study identification

NCT ID
NCT00952419
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
474 participants

Conditions and interventions

Eligibility (public fields only)

Age range
6 Months to 9 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2009 (Type not available)
Primary completion
Mar 2010 (Actual)
Completion
Jun 2010 (Actual)
Last update posted
Apr 14, 2016

2009 – 2010

United States locations

U.S. sites
20
U.S. states
11
U.S. cities
19
Facility City State ZIP Site status
Not listed Miami Beach Florida 33141 —
Not listed Marietta Georgia 30062 —
Not listed Woodstock Georgia 30189 —
Not listed Crestview Hills Kentucky 41017 —
Not listed Louisville Kentucky 40291 —
Not listed Maddisonville Kentucky 42431 —
Not listed Metairie Louisiana 70006 —
Not listed Las Vegas Nevada 89104 —
Not listed Rochester New York 14609 —
Not listed Hermitage Pennsylvania 16148 —
Not listed Pittsburgh Pennsylvania 15237 —
Not listed Pittsburgh Pennsylvania 15241 —
Not listed Cranston Rhode Island O2920 —
Not listed Barnwell South Carolina 29812 —
Not listed Austin Texas 78705 —
Not listed Fort Worth Texas 76135 —
Not listed San Angelo Texas 76904 —
Not listed Orem Utah 84057 —
Not listed South Jordan Utah 84095 —
Not listed Springville Utah 84663 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00952419, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 14, 2016 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00952419 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →